A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome
Condition: Angelman Syndrome Intervention: Drug: GTX-102 Sponsors: GeneTx Biotherapeuics, LLC.; Ultragenyx Pharmaceutical Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials